Prospect Bio
A synthetic biology company building biosensors capable of measuring chemicals and small molecules within living cells.
All edits
Biotechnology
Biology
Synthetic biology
Technology
On November 15, 2016 Prospect Bio announced raising $2.8 million in seed funding from Viking Global Investors, Viaduct Ventures, Think + Ventures, StartX, Rising Tide, Pallasite Ventures, OS Fund, Illumina, GVA LaunchGurus Fund, and 500 Startups.
Organization
StartX (Stanford-StartX Fund)
Prospect Bio is a synthetic biology company building biosensors capable of measuring chemicals and small molecules within living cells that is headquartered in Brisbane, California and was founded in 2013 by Cameron StrachanCameron Strachan and Giles Ochs. The company claims on their TROVE biosensor library has more than 10^9 naturally sourced biosensors.
Health
D2C
500 Global
Canada
Seed round
Rising Tide
Illumina
OS Fund
Viking Global Investors
Viaduct Ventures
Pallasite Ventures
B2B
Biosensor
On November 15, 2016 Prospect Bio announced raising $2.8 million in seed funding from Viking Global Investors, Viaduct VenturesViaduct Ventures, Think + Ventures, StartX, Rising Tide, Pallasite Ventures, OS Fund, Illumina, GVA LaunchGurus Fund, and 500 Startups.
